Buat hasil cerah permanen jelas butuh pemakaian rutin
Afqlir (aflibercept) was launched in Europe in November 2025, offering an affordable-treatment option for retinal diseases
A 2021 analysis of three-year follow-up data from the EDICT (Efficacy and Durability of Initial Combination Therapy) randomized controlled trial found that initiation of triple therapy with metformin, pioglitazone, and exenatide at the time of diagnosis not only led to greater improvements in HbA1C values at six months, it also significantly reduced HbA1C levels by 0.5% more than sequential initiation of metformin followed by glipizide and insulin in diabetics with a HbA1C value of approximately 9% (Abdul-Ghani 2021)
Losing 1-2 pounds per week carries significantly less telogen effluvium risk than losing 3-5 pounds per week, even if the total weight lost over time is the same
(Squibb was later acquired by Novo Nordisk, and Sharpes and Dhome stopped producing insulin and merged with Merck.) This case is often cited as the birth of the business of diabetes, as it was the first in a series of anti-competitive lawsuits targeting insulin manufacturers
Patients go through multiple levels before reaching their usual dose